Nexigen
Cologne
About Nexigen
Nexigen GmbH develops medicines to address high unmet clinical needs in oncology. Its NexiScreen screening technology identifies disease-relevant protein-protein interactions, as well as applies to various classes of intractable drug target proteins; and detects target interacting peptides (NexiTides) where common peptide interaction screening technologies can fail.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Undisclosed (May 2008)
- Website: nexigen.de
- Phone: +4922133777200
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nexigen-3280445 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.